文献速递胃肠外科围术期管理与 ERAS

机器人完整结肠系膜切除术治疗右半结肠癌:肥胖与非肥胖患者手术结局比较

Comparison of surgical outcomes of robotic complete mesocolic excision for right-sided colon cancer in obese versus non-obese patients.
PubMed 文献 · Surg Endosc · 2026-02-25

单中心回顾性队列研究纳入2015至2023年接受机器人完整结肠系膜切除术的右半结肠癌患者211例,肥胖组80例(37.9%)。肥胖组手术时间更长、出血量更多,但并发症率、淋巴结清扫数目、切缘状态及3年生存结局与非肥胖组无显著差异,提示机器人手术对肥胖患者技术可行且肿瘤学安全。

要点

  • 肥胖患者机器人完整结肠系膜切除术并发症率与非肥胖患者无显著差异。
  • 肥胖组手术时间更长(289.5 vs 247 min)、出血量更多(50 vs 30 mL)。
  • 两组淋巴结清扫数目、切缘状态及3年生存结局相当。

核心结论

  • 肥胖与更长手术时间和更多出血量相关,但不增加并发症率或恶化生存结局。
  • 机器人完整结肠系膜切除术对肥胖和非肥胖右半结肠癌患者技术上和肿瘤学上均可行。

研究设计与样本

  • 单中心回顾性队列研究,纳入2015至2023年接受机器人完整结肠系膜切除术的右半结肠癌患者211例。
  • 按BMI≥30 kg/m2定义为肥胖组(80例,37.9%),BMI<30 kg/m2为非肥胖组。

主要发现

  • 总体并发症率肥胖组18.8% vs 非肥胖组12.2%(P=0.24),III级并发症3.8% vs 1.5%(P=0.30)。
  • 两组均无血管损伤发生;中转开腹率5.0% vs 0.8%(P=0.05),住院时间相似。
  • 肥胖组手术时间289.5 vs 247 min(P=0.003),出血量50 vs 30 mL(P=0.025)。
  • 淋巴结清扫数目34.5 vs 34枚(P=0.85),两组均无环周切缘阳性。
  • 中位随访2.6年,3年无复发生存率89.1% vs 86.7%(P=0.63),总生存率100% vs 95.6%(P=0.13)。

临床怎么用

  • 肥胖不应作为机器人完整结肠系膜切除术的禁忌因素,但需预期更长手术时间和更多出血。

局限性

  • 单中心回顾性设计,样本量有限,随访时间较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A major concern of complete mesocolic excision (CME) for right-sided colon cancer is whether it can be performed safely in obese patients. The aim of this study is to perform a contemporary evaluation of the perioperative safety and oncological outcomes of robotic CME for right-sided colon cancer in obese versus non-obese patients. METHODS: This was a single-institution retrospective cohort study of patients who underwent robotic CME for right-sided colon cancer between 2015 and 2023. Patients were divided into obese (BMI ≥ 30 kg/m2) and non-obese (BMI < 30 kg/m2) groups. Perioperative complications, operative metrics, pathological results, overall survival (OS), and recurrence-free survival (RFS) were compared. RESULTS: Of 211 patients, 80 (37.9%) were obese. Complication rates did not differ significantly between obese and non-obese groups (any grade: 18.8% vs 12.2%, P = 0.24; grade III: 3.8% vs 1.5%, P = 0.30). No vascular injuries occurred in either group. Conversion rates (5.0% vs 0.8%, P = 0.05) and length of stay were similar. Obese patients had longer operative times (289.5 vs 247 min, P = 0.003) and greater blood loss (50 vs 30 mL, P = 0.025). No cases had positive circumferential resection margins. Lymph node harvest (34.5 vs 34 nodes, P = 0.85) and margin status were comparable. During median follow-up of 2.6 years, 3-year RFS was similar between groups (89.1% vs 86.7%, P = 0.63), with no significant differences in OS (100% vs 95.6%, P = 0.13). CONCLUSIONS: Obesity was associated with longer operative times and increased blood loss but not with higher complication rates or worse survival outcomes. Robotic CME appears technically and oncologically feasible for both obese and non-obese patients with right-sided colon cancer.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Miyakawa T, Ochiai K, Guraieb-Trueba M, et al. Comparison of surgical outcomes of robotic complete mesocolic excision for right-sided colon cancer in obese versus non-obese patients. Surg Endosc. 2026. PMID: 41741794. doi:10.1007/s00464-026-12650-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。